Trial Profile
A double-blind, fixed-dose study of escitalopram in adult patients with major depressive disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Forest Laboratories
- 07 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2010 Actual patient number (877) added as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.